Clinical Trial Update: Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ixazomib citrate, lenalidomide, dexamethasone, and zoledronic acid versus zoledronic acid alone after radiation in solitary osseous pla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Osseous Plasmacytoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ixazomib citrate (Ixazomib)
• Lenalidomide (lenalidomide)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Solitary Osseous Plasmacytoma | Phase 3 | Status: UNKNOWN